Petix & Botte CO Abb Vie Inc. Transaction History

Petix & Botte CO

$352 Million
Q2 2024

A detailed history of Petix & Botte CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Petix & Botte CO holds 8,618 shares of ABBV stock, worth $1.7 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

8,618

Previous 4,309 100.0%

Holding current value

$1.7 Million

Previous $784,000 88.52%

% of portfolio

0.42%

Previous 0.19%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $666,990 - $778,894	4,309 Added 100.0%	8,618 $1.48 Million
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $691,541 - $787,946	-4,327 Reduced 50.1%	4,309 $784,000
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $2,476 - $2,789	18 Added 0.21%	8,636 $1.34 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $570,985 - $710,554	4,309 Added 100.0%	8,618 $1.16 Million
Q3 2022 Oct 14, 2022	BUY	$134.21 - $153.93 $55,562 - $63,727	414 Added 10.63%	4,309 $578,000
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $536,029 - $681,469	-3,895 Reduced 50.0%	3,895 $597,000
Q1 2022 Apr 26, 2022	BUY	$131.98 - $163.75 $514,062 - $637,806	3,895 Added 100.0%	7,790 $1.26 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $413,927 - $523,738	-3,853 Reduced 49.73%	3,895 $527,000
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $412,193 - $467,901	3,874 Added 100.0%	7,748 $836,000
Q1 2021 May 24, 2021	SELL	$102.3 - $112.62 $396,310 - $436,289	-3,874 Reduced 50.0%	3,874 $419,000
Q1 2021 Apr 29, 2021	BUY	$102.3 - $112.62 $396,310 - $436,289	3,874 Added 100.0%	7,748 $420,000
Q3 2020 Oct 30, 2020	SELL	$85.91 - $100.83 $332,815 - $390,615	-3,874 Reduced 50.0%	3,874 $339,000
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $284,235 - $380,349	3,874 Added 100.0%	7,748 $381,000
Q1 2020 Apr 29, 2020	BUY	$64.5 - $97.79 $12,900 - $19,558	200 Added 5.44%	3,874 $295,000
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $265,005 - $331,578	3,674 New	3,674 $325,000

Others Institutions Holding ABBV

# of Institutions

3,695

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $348B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Petix & Botte CO, based on Form 13F filings with the SEC.

News

Stay updated on Petix & Botte CO with notifications on news.

Account